High-risk elderly patients PROSPER from cholesterol-lowering therapy

Collins, Rory; Armitage, Jane

doi:10.1016/s0140-6736(02)11650-3

Cited by 42Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismCancer, Lipids, and Metabolism

High-risk elderly patients PROSPER from cholesterol-lowering therapy

Collins, Rory, Armitage, Jane·2002·The Lancet

DOI 10.1016/s0140-6736(02)11650-3

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)11650-3

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A statin study in older adults (participants aged 70-82 years) found a 15% reduction in coronary artery disease events with pravastatin.
“A statin study in older adults (participants aged 70–82 years) found a 15% reduction in coronary artery disease events with pravastatin39, 40.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [39]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467 · see citing works
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · see citing works
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453 · see citing works
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,098 · see citing works
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,748 · see citing works
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Post Coronary Artery Bypass Graft Trial Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360301 · Cited by 953 · see citing works
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention A Randomized Controlled Trial
Serruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 716 · see citing works
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
Shepherd, J., Blauw, G. J., Murphy, M. B., Cobbe, S. M., Bollen, E. L. E. M., Buckley, B. M., Ford, I., Jukema, J. W., Hyland, M., Gaw, A., et al. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00533-0 · Cited by 449 · see citing works
Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project
Sacks, F. M., Tonkin, A. M., Shepherd, J., Braunwald, E., Cobbe, S., Hawkins, C. M., Keech, A., Packard, C., Simes, J., Byington, R., et al. (2000) · Circulation · doi:10.1161/01.cir.102.16.1893 · Cited by 388 · see citing works
THE EFFECT OF PRAVASTATIN ON CORONARY EVENTS AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH AVERAGE CHOLESTEROL LEVELS
Acks, M. S., Arc, M., Feffer, A. P., Emuel, L., Oyé, A. M., Ouleau, J. E. L. R., Utherford, J. O. D. R., Ole, T. H. G. C., Rown, L. I. B., Arnica, J. W. A. W., et al. (1996) · Cited by 321 · see citing works
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
Scandinavian Simvastation Survival Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90926-5 · Cited by 255 · see citing works
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial
Hunt, D., Young, P., Simes, J., Hague, W., Mann, S., Owensby, D., Lane, G., Tonkin, A., & for the LIPID Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00007 · Cited by 226 · see citing works
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
Prepared by the Cholesterol Treatment Trialists' (CTT) Collaboration (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80744-9 · Cited by 101 · see citing works
Effects of Pravastatin in the Elderly
Simes, J. R., Young, P., & Hunt, D. U. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-w3 · Cited by 1 · see citing works

Flagged first, then by citations

1 of the 19 references couldn’t be matched to a known paper.

Sorted by citations

Diabetes in Older Adults
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274 · see citing works
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548 · see citing works
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Cholesterol Treatment Trialists' (CTT) Collaboration (2012) · PLoS ONE · doi:10.1371/journal.pone.0029849 · Cited by 351 · see citing works
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934 · see citing works
Statins for the primary prevention of cardiovascular disease
Taylor, F. C., Ward, K. J., Moore, T. H., Burke, M., Smith, G. D., Casas, J. P., & Ebrahim, S. B. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub4 · Cited by 305 · see citing works
Association between hormone replacement therapy and subsequent stroke: a meta-analysis
Bath, P. M., & Gray, L. J. (2005) · BMJ · doi:10.1136/bmj.38331.655347.8f · Cited by 234 · see citing works
Analyses of Cancer Data from Three Ezetimibe Trials
Peto, R., Emberson, J., Landray, M., Baigent, C., Collins, R., Clare, R. M., & Califf, R. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0806603 · Cited by 230 · see citing works
Self-citation
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., & Executive, P. I. A. O. B. O. T. P. (2011) · BMJ · doi:10.1136/bmj.d1250 · Cited by 159 · see citing works
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
Rahimi, K., Bhala, N. B., Kamphuisen, P. W., Emberson, J., Biere‐Rafi, S., Krane, V., Robertson, M., Wikstrand, J., & McMurray, J. J. V. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001310 · Cited by 96 · see citing works
ACAT inhibition and amyloid beta reduction
Bhattacharyya, R., & Kovacs, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.003 · Cited by 71 · see citing works
Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
la Puente, J. B., Mata‐Cases, M., Franch‐Nadal, J., Mundet, X., Casellas, A., Fernández‐Real, J. M., & Mauricio, D. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12741 · Cited by 67 · see citing works
Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg, R. N. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1186 · Cited by 51 · see citing works
Management of Hyperlipidemia in Older Adults
Alexander, K. P., Blazing, M. A., Rosenson, R. S., Hazard, E., Aronow, W. S., Smith, S. C., & Ohman, E. M. (2009) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408328927 · Cited by 43 · see citing works
Cardiovascular Drug Therapy in the Elderly
Aronow, W. S., Frishman, W. H., & Cheng-Lai, A. (2007) · Cardiology in Review · doi:10.1097/crd.0b013e3180301b69 · Cited by 41 · see citing works
Statins for the primary prevention of cardiovascular events in older adults: A review of the evidence
Ali, R., & Alexander, K. P. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.03.008 · Cited by 38 · see citing works
Treating hypercholesterolemia: Looking forward
Gotto, A. M. (2003) · Clinical Cardiology · doi:10.1002/clc.4960261307 · Cited by 31 · see citing works
Fluvastatin treatment is not associated with an increased incidence of cancer
Stein, E. A., Corsini, A., Gimpelewicz, C. R., Bortolini, M., & GIL, M. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01071.x · Cited by 21 · see citing works
A study of statin use in the prevention of cognitive impairment of vascular origin in the UK
Suribhatla, S., Dennis, M., & Potter, J. F. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.019 · Cited by 16 · see citing works
Update on lipid-lowering therapy and LDL-cholesterol targets
Wiviott, S. D., & Cannon, C. P. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0613 · Cited by 15 · see citing works
Relation Between Plaque Progression and Low-Density Lipoprotein Cholesterol During Aging as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound of the Left Main Coronary Artery
Hartmann, M., von Birgelen, C., Mintz, G. S., van Houwelingen, G. K., Eggebrecht, H., Böse, D., Wieneke, H., Verhorst, P. M. J., & Erbel, R. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.042 · Cited by 14 · see citing works
The future of lipid-lowering therapy: the big picture.
Kastelein, J. J. P. (2003) · PubMed · Cited by 13 · see citing works
Statins in Threatened Stroke
Kaste, M. (2003) · Stroke · doi:10.1161/01.str.0000054260.05136.7d · Cited by 10 · see citing works
Lipid-modifying and antiatherosclerotic drugs
Gotto, A. M., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00019-3 · Cited by 5 · see citing works
The PROSPER trial
Little, P. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12400-2 · Cited by 5 · see citing works
Cardiovascular Drug Therapy in the Elderly
Frishman, W. H., Aronow, W. S., & Cheng-Lai, A. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.004 · Cited by 4 · see citing works
Lipid-Modifying and Antiatherosclerotic Drugs
Gotto, A. M., & Opie, L. H. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-6158-8.50015-0 · Cited by 3 · see citing works
Should we treat all patients with coronary heart disease or the equivalent with statins?
Baginsky, P. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0005-y · Cited by 2 · see citing works
Statins in the Era of Evidence-Based Medicine — Who Will Not “Prosper”?
McDougall, C., Perry, C., Sattar, N. A., & Petrie, J. R. (2003) · Scottish Medical Journal · doi:10.1177/003693300304800302 · Cited by 2 · see citing works
Nouvelles approches thérapeutiques dans la Maladie d’Alzheimer
Augy, T., Bonin‐Guillaume, S., & Blin, O. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76216-9 · Cited by 2 · see citing works
Implantable defibrillator therapy.
ALINGS, A. M. W. (2003) · PubMed · Cited by 2 · see citing works
Long-Term Medical Management of Ischemic Stroke and Transient Ischemic Attack Due to Arterial Disease
Sudlow, C. L. M., & Warlow, C. P. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50066-3 · Cited by 1 · see citing works
Are Statins Indicated for the Primary Prevention of Coronary Heart Disease in Octogenarians? Protagonist Viewpoint
Stone, N. J. (2003) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2003.02918.x · Cited by 1 · see citing works
Lipid-Altering Drugs
Goldstein, M. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1017 · Cited by 1 · see citing works
Serial intravascular ultrasound assessment of coronary atherosclerosis progression and remodeling
Hartmann, M. (2008) · doi:10.3990/1.9789071382697
Chapter 2 Primary Prevention of Stroke by Modification of Selected Risk Factors
Sloan, M. (2004) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70077-7
Lipidtherapie beim älteren Patienten: Was ist zu beachten?
Savvatis, K., von Schlippenbach, J. B. L.-G., Hp, S., & Tschöpe, C. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Edad avanzada, perfil lipoproteico y riesgo cardiovascular
Rubiés-Prat, J., & Pedro‐Botet, J. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74330-4
Associations between cardiovascular risk factors, hyper- and hypocoagulability
Rafi, S. (2011) · UvA-DARE (University of Amsterdam)
Statins Beneficial for Elders
Jarman, S. B., Frcp, Frcgp, Ffphm, & FMedSci (2003) · Journal watch · doi:10.1056/jw200301070000001
Statin Therapy Benefits Patients Aged 70 to 82
Meyer, B. J. (2003) · Journal watch · doi:10.1056/jc200301310000003
Pravastatin: A First Generation HMG CoA Reductase Inhibitor ☆
Reagan, J. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97874-7
Cholesterolverlaging bij ouderen met risico voor cardiovasculaire ziekten
(2003) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03058121

Authors: Collins, R., & Armitage, J.
Affiliations: University of Oxford (GB)
Corresponding author: Collins, Rory
ORCID: Collins, Rory
Armitage, Jane
Venue: The Lancet
Publisher: Elsevier BV
Published: 2002-11
Volume: 360
Issue: 9346
Pages: 1618-1619
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(02)11650-3
OpenAlex: W2040271175
Cited by: 42
References: 19
Citations by year: 2018: 1 · 2015: 1 · 2013: 2 · 2012: 4
FWCI: 5.45
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: PROSPER trial, statins, cholesterol-lowering therapy, elderly patients, LDL cholesterol, cardiovascular risk reduction, coronary events, stroke, revascularization, secondary prevention
MeSH terms: Aged, Aged, 80 and over, Anticholesteremic Agents, Cardiovascular Diseases, Clinical Trials as Topic, Humans, Cholesterol, LDL, Risk Factors, Pravastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-risk elderly patients PROSPER from cholesterol-lowering therapy

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks